Chemical Structure (Zarontin 01)
Zarontin Capsule
Product Images NDC 0071-0237
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zarontin (NDC 0071-0237). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Parke-davis Div Of Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Company Logo (Zarontin 02)
Distributed by Parke-Davis, a division of Pfizer Inc. located in NY, NY 10017.*
Zarontin 02a
This text indicates that a certain entity called "Parke-Davis" is distributing something. Parke-Davis is a division of another entity called "Pfizer Inc" based in New York City (NY).*
Principal Display Panel (250 mg Capsule Bottle Label)
Store ethosuximide capsules at a temperature of 25°C (77°F). The medication can be stored for short periods of time between 15-30°C (59-86°F). It is important to always dispense the medication with a child-resistant container and an accompanying medication guide. Each capsule contains 250 mg of ethosuximide, and the medication should only be dispensed with a prescription. For more information, refer to the prescribing information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
